| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3025361 | Seminars in Thoracic and Cardiovascular Surgery | 2013 | 9 Pages |
Abstract
There are a myriad of surgical therapies for patients with end-stage congestive heart failure. Coronary revascularization and mitral valve repair have clear clinical benefits in appropriately selected patients. Further investigation is required before the widespread adoption of volume-reduction strategies. Cardiac stem cell therapies have yielded promising results in preclinical and phase I studies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kevin W. Southerland, Carmelo A. Milano,